Unnamed: 0
int64 0
1.41M
| headline
stringlengths 3
513
| url
stringlengths 33
162
| publisher
stringlengths 3
46
| date
timestamp[s] | stock
stringlengths 1
5
|
---|---|---|---|---|---|
100 | Top 10 Movers Via Benzinga Pro's Screener Tool For Morning of Friday., August 16, 2019 | https://www.benzinga.com/trading-ideas/19/08/14284155/top-10-movers-via-benzinga-pros-screener-tool-for-morning-of-friday-august-16-2019 | Benzinga Newsdesk | 2019-08-16T00:00:00 | A |
101 | 75 Biggest Movers From Yesterday | https://www.benzinga.com/news/19/08/14282638/75-biggest-movers-from-yesterday | Lisa Levin | 2019-08-16T00:00:00 | A |
102 | 46 Stocks Moving In Thursday's Mid-Day Session | https://www.benzinga.com/news/19/08/14278248/46-stocks-moving-in-thursdays-mid-day-session | Lisa Levin | 2019-08-15T00:00:00 | A |
103 | Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS above analyst estimates. | https://www.benzinga.com/markets/wiim/19/08/14275943/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-ep | Benzinga Newsdesk | 2019-08-15T00:00:00 | A |
104 | A Peek Into The Markets: US Stock Futures Tumble Ahead Of Economic Data | https://www.benzinga.com/news/earnings/19/08/14273595/a-peek-into-the-markets-us-stock-futures-tumble-ahead-of-economic-data | Lisa Levin | 2019-08-15T00:00:00 | A |
105 | 10 Stocks To Watch For August 15, 2019 | https://www.benzinga.com/news/earnings/19/08/14273052/10-stocks-to-watch-for-august-15-2019 | Lisa Levin | 2019-08-15T00:00:00 | A |
106 | Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS above analyst estimates. | https://www.benzinga.com/markets/wiim/19/08/14270855/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-ep | Benzinga Newsdesk | 2019-08-14T00:00:00 | A |
107 | Agilent Technologies Sees Q4 Adj. EPS $0.84-$0.86 vs $0.87 Est., Sales $1.31B-$1.33B vs $1.34B Est., Sees FY19 Adj. EPS $3.07-$3.08 vs $3.05 Est., Sales $5.105B-$5.125B vs $5.11B Est. | https://www.benzinga.com/news/19/08/14270614/agilent-technologies-sees-q4-adj-eps-0-84-0-86-vs-0-87-est-sales-1-31b-1-33b-vs-1-34b-est-sees-fy19 | Benzinga Newsdesk | 2019-08-14T00:00:00 | A |
108 | Agilent Technologies Q3 Adj. EPS $0.76 Beats $0.72 Estimate, Sales $1.27B Beat $1.24B Estimate | https://www.benzinga.com/news/earnings/19/08/14270569/agilent-technologies-q3-adj-eps-0-76-beats-0-72-estimate-sales-1-27b-beat-1-24b-estimate | Benzinga Newsdesk | 2019-08-14T00:00:00 | A |
109 | Q3 Earnings Preview For Agilent Technologies | https://www.benzinga.com/news/earnings-previews/19/08/14262424/earnings-preview-agilent-technologies | Benzinga Newsdesk | 2019-08-14T00:00:00 | A |
110 | Earnings Scheduled For August 14, 2019 | https://www.benzinga.com/news/earnings/19/08/14262860/earnings-scheduled-for-august-14-2019 | Lisa Levin | 2019-08-14T00:00:00 | A |
111 | Shares of diagnostics and research companies are trading higher in sympathy with Syneos Health, which reported strong Q2 results and raised FY19 guidance. | https://www.benzinga.com/markets/wiim/19/08/14212087/shares-of-diagnostics-and-research-companies-are-trading-higher-in-sympathy-with-syneos-health-which | Benzinga Newsdesk | 2019-08-06T00:00:00 | A |
112 | Shares of several gold companies are trading higher amid heightened US-China trade tensions. Concerns of a trade war have led investors into 'safe-haven' assets such as gold. | https://www.benzinga.com/markets/wiim/19/08/14200364/shares-of-several-gold-companies-are-trading-higher-amid-heightened-us-china-trade-tensions-concerns | Benzinga Newsdesk | 2019-08-05T00:00:00 | A |
113 | Agilent Announces Settlement of Key Intellectual Property Case in China | https://www.benzinga.com/news/19/08/14177141/agilent-announces-settlement-of-key-intellectual-property-case-in-china | Charles Gross | 2019-08-01T00:00:00 | A |
114 | Agilent Shares Unaffected As Hearing FDA Approved Co.'s PD-L1 IHC 22C3 PharmDx Assay For Expanded Use | https://www.benzinga.com/news/19/07/14172596/agilent-shares-unaffected-as-hearing-fda-approved-co-s-pd-l1-ihc-22c3-pharmdx-assay-for-expanded-use | Benzinga Newsdesk | 2019-07-31T00:00:00 | A |
115 | Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday, July 16, 2019 | https://www.benzinga.com/trading-ideas/19/07/14081534/benzinga-pros-top-10-most-searched-tickers-for-morning-of-tuesday-july-16-2019 | Benzinga Newsdesk | 2019-07-16T00:00:00 | A |
116 | Benzinga's Top Upgrades, Downgrades For July 16, 2019 | https://www.benzinga.com/analyst-ratings/upgrades/19/07/14080665/benzingas-top-upgrades-downgrades-for-july-16-2019 | Lisa Levin | 2019-07-16T00:00:00 | A |
117 | Bank of America Downgrades Agilent Technologies to Neutral | https://www.benzinga.com/news/19/07/14079253/bank-of-america-downgrades-agilent-technologies-to-neutral | Benzinga_Newsdesk | 2019-07-16T00:00:00 | A |
118 | Barclays Downgrades Agilent Technologies to Equal-Weight, Lowers Price Target to $78 | https://www.benzinga.com/news/19/07/14071989/barclays-downgrades-agilent-technologies-to-equal-weight-lowers-price-target-to-78 | Vick Meyer | 2019-07-15T00:00:00 | A |
119 | Agilent Will Acquire BioTek Instruments In $1.16B Deal | https://www.benzinga.com/general/biotech/19/07/14059736/agilent-will-acquire-biotek-instruments-in-1-16b-deal | Tanzeel Akhtar | 2019-07-11T00:00:00 | A |
120 | Agilent To Purchase BioTek Instruments For $1.165B | https://www.benzinga.com/m-a/19/07/14059585/agilent-to-purchase-biotek-instruments-for-1-165b | Benzinga Newsdesk | 2019-07-11T00:00:00 | A |
121 | Benzinga's Top Upgrades, Downgrades For June 11, 2019 | https://www.benzinga.com/analyst-ratings/upgrades/19/06/13902075/benzingas-top-upgrades-downgrades-for-june-11-2019 | Lisa Levin | 2019-06-11T00:00:00 | A |
122 | Agilent Companion Diagnostic Receives Expanded FDA Approval For PD-L1 IHC 22C3 PharmDx | https://www.benzinga.com/news/19/06/13900892/agilent-companion-diagnostic-receives-expanded-fda-approval-for-pd-l1-ihc-22c3-pharmdx | Benzinga Newsdesk | 2019-06-11T00:00:00 | A |
123 | Piper Jaffray Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $83 Price Target | https://www.benzinga.com/news/19/06/13900616/piper-jaffray-initiates-coverage-on-agilent-technologies-with-overweight-rating-announces-83-price-t | Vick Meyer | 2019-06-11T00:00:00 | A |
124 | Shares of many Healthcare companies are trading higher as markets rebound from the recent volatility caused by uncertainty regarding US-China trade talks. Also, lawmakers were not able to pass a bill that would end 'surprise medical bills'. | https://www.benzinga.com/markets/wiim/19/05/13759342/shares-of-many-healthcare-companies-are-trading-higher-as-markets-rebound-from-the-recent-volatility | Benzinga Newsdesk | 2019-05-16T00:00:00 | A |
125 | 60 Biggest Movers From Yesterday | https://www.benzinga.com/news/19/05/13753926/60-biggest-movers-from-yesterday | Lisa Levin | 2019-05-16T00:00:00 | A |
126 | 44 Stocks Moving In Wednesday's Mid-Day Session | https://www.benzinga.com/news/19/05/13747598/44-stocks-moving-in-wednesdays-mid-day-session | Lisa Levin | 2019-05-15T00:00:00 | A |
127 | Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wed., May 15, 2019 | https://www.benzinga.com/news/19/05/13745323/benzinga-pros-top-10-most-searched-tickers-for-morning-of-wed-may-15-2019 | Benzinga Newsdesk | 2019-05-15T00:00:00 | A |
128 | Bank of America Maintains Buy on Agilent Technologies, Inc. Common Stock, Lowers Price Target to $82 | https://www.benzinga.com/news/19/05/13744668/bank-of-america-maintains-buy-on-agilent-technologies-inc-common-stock-lowers-price-target-to-82 | Vick Meyer | 2019-05-15T00:00:00 | A |
129 | Agilent Technologies shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results; the company also announced weak Q3 sales guidance. | https://www.benzinga.com/markets/wiim/19/05/13744580/agilent-technologies-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q2-eps | Benzinga âNewsdesk | 2019-05-15T00:00:00 | A |
130 | Deutsche Bank Maintains Buy on Agilent Technologies, Inc. Common Stock, Lowers Price Target to $85 | https://www.benzinga.com/news/19/05/13744046/deutsche-bank-maintains-buy-on-agilent-technologies-inc-common-stock-lowers-price-target-to-85 | Vick Meyer | 2019-05-15T00:00:00 | A |
131 | Barclays Maintains Overweight on Agilent Technologies, Inc. Common Stock, Lowers Price Target to $86 | https://www.benzinga.com/news/19/05/13743833/barclays-maintains-overweight-on-agilent-technologies-inc-common-stock-lowers-price-target-to-86 | Vick Meyer | 2019-05-15T00:00:00 | A |
132 | A Peek Into The Markets: US Stock Futures Down Ahead Of Macy's Earnings, Economic Data | https://www.benzinga.com/news/19/05/13742789/a-peek-into-the-markets-us-stock-futures-down-ahead-of-macys-earnings-economic-data | Lisa Levin | 2019-05-15T00:00:00 | A |
133 | 8 Stocks To Watch For May 15, 2019 | https://www.benzinga.com/news/earnings/19/05/13741913/8-stocks-to-watch-for-may-15-2019 | Lisa Levin | 2019-05-15T00:00:00 | A |
134 | 5 Stocks Moving In Tuesday's After-Hours Session | https://www.benzinga.com/news/19/05/13739717/5-stocks-moving-in-tuesdays-after-hours-session | Brett Hershman | 2019-05-14T00:00:00 | A |
135 | Agilent Technologies shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results; the company also issued Q3 sales guidance below analyst estimates. | https://www.benzinga.com/markets/wiim/19/05/13738494/agilent-technologies-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q2-eps | Hal Lindon | 2019-05-14T00:00:00 | A |
136 | Agilent Technologies Sees Q3 Adj. EPS $0.71-$0.73 vs $0.73 Est., Sales $1.225B-$1.245B vs $1.27B Est. Sees FY19 Adj. EPS $3.03-$3.07 vs $3.07 Est., Sales $5.085B-$5.125B vs $5.19B Est. | https://www.benzinga.com/news/19/05/13738472/agilent-technologies-sees-q3-adj-eps-0-71-0-73-vs-0-73-est-sales-1-225b-1-245b-vs-1-27b-est-sees-fy1 | Benzinga Newsdesk | 2019-05-14T00:00:00 | A |
137 | Agilent Technologies Q2 Adj. EPS $0.71 Misses $0.72 Estimate, Sales $1.24B Miss $1.27B Estimate | https://www.benzinga.com/news/earnings/19/05/13738449/agilent-technologies-q2-adj-eps-0-71-misses-0-72-estimate-sales-1-24b-miss-1-27b-estimate | Benzinga Newsdesk | 2019-05-14T00:00:00 | A |
138 | Shares of several healthcare companies are trading higher as the US market rebounds from recent weakness, driven by renewed cautious optimism surrounding US-China trade talks. | https://www.benzinga.com/markets/wiim/19/05/13736459/shares-of-several-healthcare-companies-are-trading-higher-as-the-us-market-rebounds-from-recent-weak | Benzinga Newsdesk | 2019-05-14T00:00:00 | A |
139 | 6 Stocks To Watch For May 14, 2019 | https://www.benzinga.com/news/earnings/19/05/13731379/6-stocks-to-watch-for-may-14-2019 | Lisa Levin | 2019-05-14T00:00:00 | A |
140 | Earnings Scheduled For May 14, 2019 | https://www.benzinga.com/news/earnings/19/05/13731335/earnings-scheduled-for-may-14-2019 | Lisa Levin | 2019-05-14T00:00:00 | A |
141 | Shares of several healthcare companies are trading lower in sympathy with the overall market. The S&P 500 is trading lower 1% | https://www.benzinga.com/markets/wiim/19/05/13717298/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-the-s-p | Benzinga Newsdesk | 2019-05-10T00:00:00 | A |
142 | 10 Biggest Price Target Changes For Tuesday | https://www.benzinga.com/analyst-ratings/price-target/19/03/13424112/10-biggest-price-target-changes-for-tuesday | Lisa Levin | 2019-03-26T00:00:00 | A |
143 | Cowen & Co. Maintains Outperform on Agilent Technologies, Raises Price Target to $90 | https://www.benzinga.com/news/19/03/13422582/cowen-co-maintains-outperform-on-agilent-technologies-raises-price-target-to-90 | Vick Meyer | 2019-03-26T00:00:00 | A |
144 | Benzinga's Top Upgrades, Downgrades For March 15, 2019 | https://www.benzinga.com/analyst-ratings/upgrades/19/03/13367957/benzingas-top-upgrades-downgrades-for-march-15-2019 | Lisa Levin | 2019-03-15T00:00:00 | A |
145 | UBS Initiates Coverage On Agilent Technologies with Buy Rating, Announces $92 Price Target | https://www.benzinga.com/news/19/03/13367090/ubs-initiates-coverage-on-agilent-technologies-with-buy-rating-announces-92-pric | Vick Meyer | 2019-03-15T00:00:00 | A |
146 | Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $83 | https://www.benzinga.com/news/19/02/13217736/barclays-maintains-overweight-on-agilent-technologies-raises-price-target-to-83 | Vick Meyer | 2019-02-21T00:00:00 | A |
147 | UPDATE: Agilent Raises FY19 Adj. EPS Guidance From $3-$3.05 To $3.03-$3.07 vs $3.05 Estimate, Sales From $5.13B-$5.17B To $5.15B-$5.19B vs $5.17B Est. | https://www.benzinga.com/news/19/02/13212634/update-agilent-raises-fy19-adj-eps-guidance-from-3-3-05-to-3-03-3-07-vs-3-05-est | Benzinga Newsdesk | 2019-02-20T00:00:00 | A |
148 | Agilent Sees Q2 Adj. EPS $0.70-$0.72 vs $0.72 Estimate, Sales $1.255B-$1.27B vs $1.27B Est.; Raises FY19 Guidance | https://www.benzinga.com/news/19/02/13212621/agilent-sees-q2-adj-eps-0-70-0-72-vs-0-72-estimate-sales-1-255b-1-27b-vs-1-27b-e | Benzinga Newsdesk | 2019-02-20T00:00:00 | A |
149 | Agilent Technologies Q1 EPS $0.76 Beats $0.73 Estimate, Sales $1.284B Beat $1.27B Estimate | https://www.benzinga.com/news/earnings/19/02/13212600/agilent-technologies-q1-eps-0-76-beats-0-73-estimate-sales-1-284b-beat- | Benzinga Newsdesk | 2019-02-20T00:00:00 | A |
150 | 10 Stocks To Watch For February 20, 2019 | https://www.benzinga.com/news/earnings/19/02/13206712/10-stocks-to-watch-for-february-20-2019 | Lisa Levin | 2019-02-20T00:00:00 | A |
151 | Earnings Scheduled For February 20, 2019 | https://www.benzinga.com/news/earnings/19/02/13206658/earnings-scheduled-for-february-20-2019 | Lisa Levin | 2019-02-20T00:00:00 | A |
152 | JANA 13F Shows Liquidated Stakes In Alibaba, Agilent, US Steel, SVMK, Electronic Arts, Dollar Tree | https://www.benzinga.com/news/19/02/13174159/jana-13f-shows-liquidated-stakes-in-alibaba-agilent-us-steel-svmk-electronic-art | Benzinga Newsdesk | 2019-02-14T00:00:00 | A |
153 | 8 Biggest Price Target Changes For Tuesday | https://www.benzinga.com/analyst-ratings/price-target/19/02/13149455/8-biggest-price-target-changes-for-tuesday | Lisa Levin | 2019-02-12T00:00:00 | A |
154 | Deutsche Bank Maintains Buy on Agilent Technologies, Raises Price Target to $85 | https://www.benzinga.com/news/19/02/13147998/deutsche-bank-maintains-buy-on-agilent-technologies-raises-price-target-to-85 | Vick Meyer | 2019-02-12T00:00:00 | A |
155 | Agilent Technologies Option Alert: Mar 15 $75 Calls at the Ask: 1000 @ $2.3 vs 33 OI; Earnings 2/20 After Close Ref=$73.74 | https://www.benzinga.com/markets/options/19/01/13056183/agilent-technologies-option-alert-mar-15-75-calls-at-the-ask-1000-2-3 | Charles Gross | 2019-01-29T00:00:00 | A |
156 | Needham Initiates Coverage On Agilent Technologies with Buy Rating, Announces $77 Price Target | https://www.benzinga.com/news/19/01/12924487/needham-initiates-coverage-on-agilent-technologies-with-buy-rating-announces-77- | Vick Meyer | 2019-01-03T00:00:00 | A |
157 | 50 Biggest Movers From Yesterday | https://www.benzinga.com/news/18/11/12737162/50-biggest-movers-from-yesterday | Lisa Levin | 2018-11-21T00:00:00 | A |
158 | 36 Stocks Moving In Tuesday's Mid-Day Session | https://www.benzinga.com/news/18/11/12733299/36-stocks-moving-in-tuesdays-mid-day-session | Lisa Levin | 2018-11-20T00:00:00 | A |
159 | Shares of Agilent Technologies are trading up 6% after the company beat Q4 Earnings estimates and issued upbeat FY19 guidance. | https://www.benzinga.com/markets/wiim/18/11/12733017/shares-of-agilent-technologies-are-trading-up-6-after-the-company-beat-q | Benzinga Newsdesk | 2018-11-20T00:00:00 | A |
160 | Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $89 | https://www.benzinga.com/news/18/11/12732252/morgan-stanley-maintains-overweight-on-agilent-technologies-raises-price-target- | Vick Meyer | 2018-11-20T00:00:00 | A |
161 | 26 Stocks Moving In Tuesday's Pre-Market Session | https://www.benzinga.com/news/18/11/12730696/26-stocks-moving-in-tuesdays-pre-market-session | Lisa Levin | 2018-11-20T00:00:00 | A |
162 | 10 Stocks To Watch For November 20, 2018 | https://www.benzinga.com/news/earnings/18/11/12729524/10-stocks-to-watch-for-november-20-2018 | Lisa Levin | 2018-11-20T00:00:00 | A |
163 | 6 Stocks Moving In Monday's After-Hours Session | https://www.benzinga.com/news/18/11/12727689/6-stocks-moving-in-mondays-after-hours-session | Brett Hershman | 2018-11-19T00:00:00 | A |
164 | Agilent Sees Q1 Adj. EPS $0.71-$0.73 vs $0.72 Estimate, Sales $1.265B-$1.28B vs $1.27B Est. | https://www.benzinga.com/news/18/11/12726764/agilent-sees-q1-adj-eps-0-71-0-73-vs-0-72-estimate-sales-1-265b-1-28b-vs-1-27b-e | Benzinga Newsdesk | 2018-11-19T00:00:00 | A |
165 | Agilent Sees FY19 Adj. EPS $3-$3.05 vs $2.96 Estimate, Sales $5.13B-$5.17B vs $5.18B Est. | https://www.benzinga.com/news/18/11/12726760/agilent-sees-fy19-adj-eps-3-3-05-vs-2-96-estimate-sales-5-13b-5-17b-vs-5-18b-est | Benzinga Newsdesk | 2018-11-19T00:00:00 | A |
166 | Agilent Technologies, Inc. Q4 EPS $0.81 Beats $0.74 Estimate, Sales $1.29B Beat $1.25B Estimate | https://www.benzinga.com/news/earnings/18/11/12726755/agilent-technologies-inc-q4-eps-0-81-beats-0-74-estimate-sales-1-29b-be | Benzinga Newsdesk | 2018-11-19T00:00:00 | A |
167 | 8 Stocks To Watch For November 19, 2018 | https://www.benzinga.com/news/earnings/18/11/12721643/8-stocks-to-watch-for-november-19-2018 | Lisa Levin | 2018-11-19T00:00:00 | A |
168 | Earnings Scheduled For November 19, 2018 | https://www.benzinga.com/news/earnings/18/11/12721567/earnings-scheduled-for-november-19-2018 | Lisa Levin | 2018-11-19T00:00:00 | A |
169 | 13F From JANA Shows Cut Stake In Agilent | https://www.benzinga.com/news/18/11/12696733/13f-from-jana-shows-cut-stake-in-agilent | Benzinga Newsdesk | 2018-11-14T00:00:00 | A |
170 | Agilent Highlights Letter To SEC Related To Material Misstatements In Twist Bioscience's S-1 | https://www.benzinga.com/news/18/10/12584510/agilent-highlights-letter-to-sec-related-to-material-misstatements-in-twist-bios | Benzinga Newsdesk | 2018-10-29T00:00:00 | A |
171 | Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $86 | https://www.benzinga.com/news/18/10/12483208/morgan-stanley-maintains-overweight-on-agilent-technologies-raises-price-target- | Vick Meyer | 2018-10-10T00:00:00 | A |
172 | A Peek Into The Markets: US Stock Futures Up; All Eyes On Fed Decision | https://www.benzinga.com/news/18/09/12408628/a-peek-into-the-markets-us-stock-futures-up-all-eyes-on-fed-decision | Lisa Levin | 2018-09-26T00:00:00 | A |
173 | Agilent Technologies To Acquire ACEA Biosciences; Financial Terms Not Disclosed | https://www.benzinga.com/news/18/09/12408423/agilent-technologies-to-acquire-acea-biosciences-financial-terms-not-disclosed | Benzinga_Newsdesk | 2018-09-26T00:00:00 | A |
174 | Agilent to Acquire ACEA Biosciences for $250M in Cash | https://www.benzinga.com/news/18/09/12408192/agilent-to-acquire-acea-biosciences-for-250m-in-cash | Charles Gross | 2018-09-26T00:00:00 | A |
175 | A Life Science Tools And Diagnostics Pair Trade: Goldman Recommends Buying Agilent, Moving to Sidelines On Thermo Fisher | https://www.benzinga.com/analyst-ratings/analyst-color/18/09/12363481/a-life-science-tools-and-diagnostics-pair-trade-goldman | Shanthi Rexaline | 2018-09-17T00:00:00 | A |
176 | Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma, PD-L1 IHC 22C3 pharmDx Now Approved to Identify Certain Urothelial Carcinoma Patients for Treatment With KEYTRUDA | https://www.benzinga.com/news/18/08/12238386/agilent-companion-diagnostic-gains-expanded-fda-approval-in-urothelial-carcinoma | Benzinga_Newsdesk | 2018-08-21T00:00:00 | A |
177 | Deutsche Bank Maintains Buy on Agilent Technologies, Raises Price Target to $80 | https://www.benzinga.com/news/18/08/12208991/deutsche-bank-maintains-buy-on-agilent-technologies-raises-price-target-to-80 | Vick Meyer | 2018-08-15T00:00:00 | A |
178 | 30 Stocks Moving In Wednesday's Pre-Market Session | https://www.benzinga.com/news/18/08/12208634/30-stocks-moving-in-wednesdays-pre-market-session | Lisa Levin | 2018-08-15T00:00:00 | A |
179 | Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $84 | https://www.benzinga.com/news/18/08/12208285/morgan-stanley-maintains-overweight-on-agilent-technologies-raises-price-target- | Vick Meyer | 2018-08-15T00:00:00 | A |
180 | A Peek Into The Markets: US Stock Futures Tumble Ahead Of Economic Reports | https://www.benzinga.com/news/18/08/12208171/a-peek-into-the-markets-us-stock-futures-tumble-ahead-of-economic-reports | Lisa Levin | 2018-08-15T00:00:00 | A |
181 | 10 Stocks To Watch For August 15, 2018 | https://www.benzinga.com/news/earnings/18/08/12207581/10-stocks-to-watch-for-august-15-2018 | Lisa Levin | 2018-08-15T00:00:00 | A |
182 | Agilent Technologies Q3 Adj. EPS $0.67 Beats $0.63 Estimate, Sales $1.203B Beat $1.2B Estimate | https://www.benzinga.com/news/earnings/18/08/12205480/agilent-technologies-q3-adj-eps-0-67-beats-0-63-estimate-sales-1-203b-b | Benzinga Newsdesk | 2018-08-14T00:00:00 | A |
183 | 13F Filing From Tiger Global Shows Dissolved Stake In Activision, Agilent, Altria, and American Express | https://www.benzinga.com/general/hedge-funds/18/08/12203728/13f-filing-from-tiger-global-shows-dissolved-stake-in-activision- | Benzinga Newsdesk | 2018-08-14T00:00:00 | A |
184 | Jana Partners 13F shows Increased Stake In Agilent Technologies From ~1.02M Shares To ~1.22M Shares | https://www.benzinga.com/news/18/08/12200786/jana-partners-13f-shows-increased-stake-in-agilent-technologies-from-1-02m-share | Benzinga Newsdesk | 2018-08-14T00:00:00 | A |
185 | Agilent Technologies Q3 Earnings Preview | https://www.benzinga.com/news/earnings-previews/18/08/12197068/agilent-technologiess-earnings-preview | Benzinga Newsdesk | 2018-08-14T00:00:00 | A |
186 | Earnings Scheduled For August 14, 2018 | https://www.benzinga.com/news/earnings/18/08/12197301/earnings-scheduled-for-august-14-2018 | Lisa Levin | 2018-08-14T00:00:00 | A |
187 | 10 Stocks To Watch For August 14, 2018 | https://www.benzinga.com/news/earnings/18/08/12197267/10-stocks-to-watch-for-august-14-2018 | Lisa Levin | 2018-08-14T00:00:00 | A |
188 | Agilent Announces CFO Didier Hirsch To Retire October 31, Robert McMahon To Become CFO | https://www.benzinga.com/news/18/07/12111267/agilent-announces-cfo-didier-hirsch-to-retire-october-31-robert-mcmahon-to-becom | Benzinga Newsdesk | 2018-07-31T00:00:00 | A |
189 | Waters Has Limited Upside Potential To Growth Expectations; Janney Steps to The Sidelines | https://www.benzinga.com/analyst-ratings/analyst-color/18/07/12030082/waters-has-limited-upside-potential-to-growth-expectati | Shanthi Rexaline | 2018-07-17T00:00:00 | A |
190 | Agilent, Nanyang Technological University Singapore to Develop Novel Approaches for Water Analysis | https://www.benzinga.com/news/18/07/11989733/agilent-nanyang-technological-university-singapore-to-develop-novel-approaches-f | Benzinga Newdesk | 2018-07-09T00:00:00 | A |
191 | Agilent Companion Diagnostic Gains Expanded FDA Approval In Cervical Cancer | https://www.benzinga.com/news/18/06/11869095/agilent-companion-diagnostic-gains-expanded-fda-approval-in-cervical-cancer | Benzinga Newsdesk | 2018-06-12T00:00:00 | A |
192 | Agilent to Acquire Assets of Ultra Scientific, No Financial Terms Disclosed | https://www.benzinga.com/news/m-a/18/05/11800815/agilent-to-acquire-assets-of-ultra-scientific-no-financial-terms-disclosed | Benzinga Newsdesk | 2018-05-30T00:00:00 | A |
193 | Agilent, University of Duisburg-Essen Announce Collaboration Agreement | https://www.benzinga.com/news/contracts/18/05/11772296/agilent-university-of-duisburg-essen-announce-collaboration-agreement | Benzinga Newsdesk | 2018-05-24T00:00:00 | A |
194 | Agilent Signs Agreement to Acquire Assets from Young in Scientific Co. Ltd.; Financial Terms Not Disclosed | https://www.benzinga.com/news/m-a/18/05/11761813/agilent-signs-agreement-to-acquire-assets-from-young-in-scientific-co-ltd-fi | Benzinga Newdesk | 2018-05-23T00:00:00 | A |
195 | Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week | https://www.benzinga.com/general/biotech/18/05/11744154/pot-stocks-etfs-top-news-and-data-from-the-cannabis-industry-this-wee | Javier Hasse | 2018-05-18T00:00:00 | A |
196 | 45 Biggest Movers From Yesterday | https://www.benzinga.com/news/18/05/11723622/45-biggest-movers-from-yesterday | Lisa Levin | 2018-05-16T00:00:00 | A |
197 | 37 Stocks Moving In Tuesday's Mid-Day Session | https://www.benzinga.com/news/18/05/11716776/37-stocks-moving-in-tuesdays-mid-day-session | Lisa Levin | 2018-05-15T00:00:00 | A |
198 | Cowen & Co. Upgrades Agilent Technologies to Outperform | https://www.benzinga.com/news/18/05/11715495/cowen-co-upgrades-agilent-technologies-to-outperform | Benzinga Newsdesk | 2018-05-15T00:00:00 | A |
199 | Traders Circulating Chatter That Cowen Upgraded Agilent | https://www.benzinga.com/analyst-ratings/upgrades/18/05/11715253/traders-circulating-chatter-that-cowen-upgraded-agilent | Benzinga Newsdesk | 2018-05-15T00:00:00 | A |